ROCK2 and colonic neoplasm: To characterize the participation of the ROCK-dependent signalling pathway in the invasive capacity of human colon cancer cells, SW620 cells were treated with the potent ROCK-1 and ROCK-2 inhibitor Y-27632 at a concentration of 10 μM.